0089: A Two-Stage, Phase Ii, Multi-Center Pilot Study of Intravenous Paclitaxel, Carboplatin, and Bevaci-Zumab Followed By Paclitaxel and Bevacizumab Consolidation Therapy in Patients with Newly Diagnosed Stage Iii/Iv Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer